Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
Completed · Phase 4
Conditions studied: Intraocular Pressure
In brief
The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
Key facts
- Study ID
- NCT00828477
- Run by
- Bp Consulting, Inc
- People needed
- 25
- Starts
- 2009-01-01
- Expected to finish
- 2009-06-01
- Last updated by the study team
- 2009-06-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- > 18 years old, either gender or any race.
- Diagnosis of open-angle glaucoma or ocular hypertension requiring laser trabeculoplasty.
- Completion of written and informed consent/authorization prior to any study related procedures.
- Able to follow study protocol and likely to complete study schedule.
You may not qualify if…
- Known sensitivity to NSAIDs.
- History of neovascular or ocular inflammatory disease.
- Current use of topical or systemic anti-inflammatory medications.
- Females of childbearing potential.
Where it is running
- Coburn-Kleinfeldt Eye Clinic — 3340 6 Mile Rd Livonia, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.